ArticleCancer research2010

Development of a novel tumor-targeted vascular disrupting agent activated by membrane-type matrix metalloproteinases.

Jennifer M Atkinson et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.